Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis Meeting Abstract


Authors: Kristeleit, R.; Swisher, E.; Oza, A.; Coleman, R. L.; Scott, C.; Konecny, G.; Tinker, A.; O'Malley, D. M.; Brenton, J.; Bell-Mcguinn, K.; Oaknin, A.; Leary, A.; Lin, K. K.; Raponi, M.; Giordano, H.; Maloney, L.; Goble, S.; Yelensky, R.; McNeish, I.
Abstract Title: Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S531
Language: English
ACCESSION: WOS:000361887402354
PROVIDER: wos
DOI: 10.1016/S0959-8049(15)30050-2
Notes: Meeting Abstract: 2700 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors